Countess of Chester Hospital Inquiry

Debate between Mike Amesbury and Steve Barclay

Monday 4th September 2023 Commons Chamber

[Mike Amesbury (Weaver Vale) (Lab)]

I and my Cheshire West and Chester constituents are served by the Countess of Chester Hospital, so I welcome the inquiry’s having been put on a statutory footing, but like other hon. Members across the House, and, in particular, the families of the victims of this horrendous situation, I want to ensure that those managers who have somehow recycled themselves into leadership positions face stronger regulation and accountability. I look forward to the Secretary of State’s expanding on that.

[Steve Barclay]

It will not surprise the hon. Gentleman that a central concern of the families when I met them was the extent to which they felt fobbed off when concerns were raised and the ability of those managers either to continue in post or to move to new posts. I think that concern is shared across the House. It is very much central to some of the safeguards that have been put in place through the recommendations from Kark that have already been accepted. It also opens up questions about the role of boards and how we strengthen non-executive directors, the training and induction, and the other provisions that we can put in place. Of course, some of those issues are the reason we are having the inquiry, and through the statutory process, there will be the opportunity to call people to give evidence and for the judge-led inquiry to put questions on behalf of the families.

Oral Answers to Questions

Debate between Mike Amesbury and Steve Barclay

Tuesday 11th July 2023 Commons Chamber

[Steve Barclay]

Dr Alex George does a lot of fantastic work. I am due to meet him shortly in the coming days, and I look forward to that discussion. My hon. Friend is right to highlight the importance of getting more mental health support into the community, which is exactly what our additional funding is focused on delivering.

[Mike Amesbury (Weaver Vale) (Lab)]

Eighteen community pharmacists in my constituency are reporting challenges on medicine supplies. What more is the Minister going to do to get a grip of this situation?

[Steve Barclay]

We have a long-standing team in the Department focused on medical supplies, which are a continual issue; as a matter of routine business, there are often challenges in that area. If the hon. Gentleman has specific issues he wishes to raise, we would be happy to look at them, but we have a dedicated team in the Department that focuses on that exact point.

Oral Answers

Debate between Mike Amesbury and Steve Barclay

Tuesday 25th April 2023 Commons Chamber

[Steve Barclay]

The hon. Lady raises an important issue related to MS. I am happy to write to her with a more detailed answer about the capability and the plan. There is always a tendency within government to lurch to a strategy rather than to look at what is needed for immediate delivery. I will happily set out what steps we are taking now as part of our pandemic recovery in order to target the workforce within the constraints that she raises.

[Mike Amesbury (Weaver Vale) (Lab)]

14. What steps he is taking to improve access to in-home health and social care services.

Urgent and Emergency Care Recovery Plan

Debate between Mike Amesbury and Steve Barclay

Monday 30th January 2023 Commons Chamber

[Steve Barclay]

I recognise my hon. Friend’s point, not least as a rural constituency MP myself. I have talked to paramedics, as I am sure he has, and the principal cause of frustration of late has not been the issue of pay—important though that is. It has been frustration over long handover times, which has had a particularly damaging impact. I am happy to look at any specific issues in his area but he is right on the wider point about the pressures in rural areas.

[Mike Amesbury (Weaver Vale) (Lab)]

When can the people of Warrington, and indeed Halton, expect to hear about the new hospital campuses, which are much needed by both communities—with sufficient staff to resource them?

Oral Answers to Questions

Debate between Mike Amesbury and Steve Barclay

Thursday 25th November 2021 Commons Chamber

[Mike Amesbury (Weaver Vale) (Lab)]

11. What steps he is taking to increase opportunities for British businesses to bid for contracts on major infrastructure projects.

[The Chancellor of the Duchy of Lancaster and Minister for the Cabinet Office (Steve Barclay)]

Small and medium-sized businesses are the backbone of the UK economy. We are increasing opportunities for SMEs in a variety of ways, from transparently publishing contract pipelines to simplifying the bidding process.

[Steve Barclay]

My hon. Friend is right to be proud of those industries, and he is also right to draw a distinction between contracts above £10,000, which need to be published, and those below £10,000, albeit of course that those below £10,000 still need to deliver value for money. We are looking, through the legislation that we are bringing forward on procurement, at how we can allow greater comparability in public contracts—that £300 billion of spend—so that we drive better value for money. We are also supporting SMEs through things such as Help to Grow: Digital and Help to Grow: Management in order that they are better enabled to bid for those important contracts.

[Mike Amesbury]

The rows and rows of wind turbines off our shores have, historically, largely been imported from abroad. What are the Government and the Minister doing to ensure that onshore and offshore renewable technology is British made using British steel?

[Steve Barclay]

There are two aspects to that question. First, there is the investment we are making—for example, the £15 billion, increasing to £20 billion, in research and development so that we can make the most of innovation and technical opportunities, building on our university sector expertise. Secondly, covid has shone a light on the importance of resilience in supply chains and the benefits in certain sectors of onshoring more of our supply chains. I think that is one positive that has come out of the covid process.